KEGG   DRUG: Cantuzumab ravtansine
Entry
D10454                      Drug                                   
Name
Cantuzumab ravtansine (USAN/INN)
Formula
C6570H10130N1726O2018S44(C42H59ClN3O11S2)n
Sequence
(Heavy chain)
XVQLVQSGAE VKKPGETVKI SCKASDYTFT YYGMNWVKQA PGQGLKWMGW IDTTTGEPTY
AQKFQGRIAF SLETSASTAY LQIKSLKSED TATYFCARRG PYNWYFDVWG QGTTVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
DIVMTQSPLS VPVTPGEPVS ISCRSSKSLL HSNGNTYLYW FLQRPGQSPQ LLIYRMSNLV
SGVPDRFSGS GSGTAFTLRI SRVEAEDVGV YYCLQHLEYP FTFGPGTKLE LKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H146-H202, H222-L219 H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'219, H'263-H'323, H'369-H'427, L23-L93, L139-L'199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Antibody-drug conjugate
Target
  Pathway
hsa04540  Gap junction
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    TUBB
     D10454  Cantuzumab ravtansine (USAN/INN)
Other DBs
CAS: 868747-45-9
PubChem: 172232547
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system